Skip to content

Study · In vitro (cells) · 2015

7 results

Mechano-growth factor enhances differentiation of bone marrow-derived mesenchymal stem cells.

Li H, Lei M, Luo Z, Wu S, Zhong L, Xu Z, Lv Y, Yang L

Biotechnology letters2 Sept 2015Cited by 10 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In human bone marrow-derived mesenchymal stem cells, MGF E peptide significantly increased osteogenic differentiation.

    In plain wordsIn cells, the MGF E peptide made human bone marrow stem cells turn into bone cells more.

    Outcome
    IncreaseOsteogenic differentiation of hBMSCs
    Study

    humann: not reported in source

    human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Alizarin Red S, Oil Red O and Alcian Blue staining showed osteogenic, adipogenic and chondrogenic differentiation were significantly increased after hBMSCs were treated with MGF E peptide.
    1 context sentence
    Summary · context
    To investigate the effect of mechano-growth factor (MGF) on the differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro.
  2. 02LabIn vitro (cells)Efficacy outcome

    In human bone marrow-derived mesenchymal stem cells, MGF E peptide significantly increased adipogenic differentiation.

    In plain wordsIn cells, the MGF E peptide made human bone marrow stem cells turn into fat cells more.

    Outcome
    IncreaseAdipogenic differentiation of hBMSCs
    Study

    humann: not reported in source

    human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Alizarin Red S, Oil Red O and Alcian Blue staining showed osteogenic, adipogenic and chondrogenic differentiation were significantly increased after hBMSCs were treated with MGF E peptide.
    1 context sentence
    Summary · context
    To investigate the effect of mechano-growth factor (MGF) on the differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro.
  3. 03LabIn vitro (cells)Efficacy outcome

    In human bone marrow-derived mesenchymal stem cells, MGF E peptide significantly increased chondrogenic differentiation.

    In plain wordsIn cells, the MGF E peptide made human bone marrow stem cells turn into cartilage cells more.

    Outcome
    IncreaseChondrogenic differentiation of hBMSCs
    Study

    humann: not reported in source

    human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Alizarin Red S, Oil Red O and Alcian Blue staining showed osteogenic, adipogenic and chondrogenic differentiation were significantly increased after hBMSCs were treated with MGF E peptide.
    1 context sentence
    Summary · context
    To investigate the effect of mechano-growth factor (MGF) on the differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro.
  4. 04LabIn vitro (cells)Mechanism

    In hBMSCs, the proliferation rate was decreased after MGF treatment compared with the control group.

    In plain wordsIn cells, MGF treatment slowed the growth of human bone marrow stem cells compared with untreated cells.

    Outcome
    DecreasehBMSC proliferation rate
    Study

    humann: not reported in source

    human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro
    Comparator
    Control group
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    hBMSCs proliferation rate was decreased and G1 phase of the cell cycle was lengthened after MGF treatment when compared to the control group.
    1 context sentence
    Summary · context
    To investigate the effect of mechano-growth factor (MGF) on the differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro.
  5. 05LabIn vitro (cells)Mechanism

    In hBMSCs, the G1 phase of the cell cycle was lengthened after MGF treatment compared with the control group.

    In plain wordsIn cells, MGF treatment lengthened one phase of the cell cycle compared with untreated cells.

    Outcome
    IncreaseG1 phase length of the cell cycle
    Study

    humann: not reported in source

    human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro
    Comparator
    Control group
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    G1 phase of the cell cycle was lengthened after MGF treatment when compared to the control group.
    1 context sentence
    Summary · context
    To investigate the effect of mechano-growth factor (MGF) on the differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro.

Studies that did not test the peptide alone2

In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking MGF / PEG-MGF.

  1. 06LabNot a test of MGF / PEG-MGF aloneIn vitro (cells)Efficacy outcome

    In hBMSCs, Collagen II expression was considerably increased with chondrogenic medium supplemented with TGF-β3 and MGF E peptide. The abstract names no comparator without the peptide.

    In plain wordsIn cells, Collagen II rose with TGF-β3 and MGF E peptide together. The abstract does not show the effect of the peptide alone.

    Outcome
    IncreaseCollagen II expression with TGF-β3 and MGF E peptide
    Study

    humann: not reported in source

    human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal

    Source sentences

    Summary
    Collagen II expression was considerably increased after hBMSCs were induced with chondrogenic induction culture medium supplemented with TGF-β3 and MGF E peptide.
    1 context sentence
    Summary · context
    To investigate the effect of mechano-growth factor (MGF) on the differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

  2. 07LabNot a test of MGF / PEG-MGF aloneIn vitro (cells)Efficacy outcome

    In hBMSCs, overexpression of MGF by an expression plasmid enhanced tri-lineage differentiation.

    In plain wordsIn cells, adding an MGF gene on a plasmid increased how much stem cells turned into three cell types.

    Outcome
    IncreaseTri-lineage differentiation after MGF overexpression by plasmid
    Study

    humann: not reported in source

    human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal

    Source sentences

    Summary
    Overexpression of MGF by an expression plasmid further confirmed the MGF could enhance tri-lineage differentiation of hBMSCs.
    1 context sentence
    Summary · context
    To investigate the effect of mechano-growth factor (MGF) on the differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) in vitro.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.